The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...

Swiss drugmaker Novartis has opened a new viral vector production plant in Menges, central Slovenia, following an investment ...

OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies ...

Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...

Tax advantages offered by PEA-PME and PEA are only available to French residents. *Shares of European companies with fewer than 5,000 employees and an annual revenue of less than €1.5 billion or total ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...